- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05080894
Virtual Reality Rehabilitation for Patients With Anterior Cruciate Ligament Reconstruction
April 16, 2024 updated by: Prof. Maria V. Sanchez-Vives, Institut d'Investigacions Biomèdiques August Pi i Sunyer
Early Domestic Rehabilitation Using Virtual Reality for Patients With Anterior Cruciate Ligament Reconstruction: a Randomized Controlled Trial
The purpose of this study is to ascertain whether 4 weeks of daily virtual-reality-based rehabilitation at home improves disability in the early stages of recovery from anterior cruciate ligament reconstruction surgery compared with standard care.
Study Overview
Detailed Description
After being informed about the study and potential risks and benefits, patients giving written informed consent will be randomized to one of two groups in a 1:1 ratio.
The treatment group will perform daily a 20-minute rehabilitation session in virtual reality, in which they will observe their virtual body performing a series of exercises they would otherwise be unable to perform in real life.
Both groups will also undergo the standard rehabilitation protocol.
The investigators will assess for differences between groups in self-reported disability, knee range of motion, and quadriceps strength at baseline, 4 weeks, 12 weeks and 9 months.
Study Type
Interventional
Enrollment (Actual)
44
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Maria V. Sanchez-Vives, PhD
- Phone Number: 4379/4302 93 227 5400
- Email: msanche3@clinic.cat
Study Contact Backup
- Name: Tony G Donegan, MSc
- Phone Number: 4379/4302 93 227 5400
- Email: donegan@clinic.cat
Study Locations
-
-
-
Barcelona, Spain, 08036
- IDIBAPS
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Aged 18-40 (either sex)
- Post-operative anterior cruciate ligament reconstruction (autograft), either bone-patellar tendon-bone graft or semitendinosus (hamstring) graft
Exclusion Criteria:
- Patients with significant cognitive deficit (MEC<24).
- Patients with epilepsy or severe vision problems
- Pregnant patients
- Previous surgery on the reconstructed knee, excluding arthroscopy
- Previous anterior cruciate ligament reconstruction on either knee
- Sustained concurrent injury to the contralateral knee
- Concomitant collateral ligament and/or meniscal repair
- Presence of symptomatic tibiofemoral osteoarthritis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Virtual reality
Daily 20-minute sessions of virtual reality based rehabilitation for the first 4 weeks post-operatively + standard rehabilitation protocol
|
Embodiment of a healthy virtual body in virtual reality and action observation/motor imagery of the subject's virtual body performing high-level lower limb exercises.
|
No Intervention: Standard intervention
Standard rehabilitation protocol only
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The International Knee Documentation Committee (IKDC) Subjective Knee Form
Time Frame: Baseline (day 1 post-surgery)
|
Patient-completed tool, which contains sections on knee symptoms/pain, function, and sports activities.
Scores range from 0 points (lowest level of function or highest level of symptoms) to 100 points (highest level of function and lowest level of symptoms).
|
Baseline (day 1 post-surgery)
|
The International Knee Documentation Committee (IKDC) Subjective Knee Form
Time Frame: 4 weeks
|
Patient-completed tool, which contains sections on knee symptoms/pain, function, and sports activities.
Scores range from 0 points (lowest level of function or highest level of symptoms) to 100 points (highest level of function and lowest level of symptoms).
|
4 weeks
|
The International Knee Documentation Committee (IKDC) Subjective Knee Form
Time Frame: 12 weeks
|
Patient-completed tool, which contains sections on knee symptoms/pain, function, and sports activities.
Scores range from 0 points (lowest level of function or highest level of symptoms) to 100 points (highest level of function and lowest level of symptoms).
|
12 weeks
|
The International Knee Documentation Committee (IKDC) Subjective Knee Form
Time Frame: 9 months
|
Patient-completed tool, which contains sections on knee symptoms/pain, function, and sports activities.
Scores range from 0 points (lowest level of function or highest level of symptoms) to 100 points (highest level of function and lowest level of symptoms).
|
9 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Isometric quadriceps strength
Time Frame: Baseline
|
Measured knee extension strength with a handheld dynamometer, expressed as peak force (Newtons)
|
Baseline
|
Isometric quadriceps strength
Time Frame: 4 weeks
|
Measured knee extension strength with a handheld dynamometer, expressed as peak force (Newtons)
|
4 weeks
|
Isometric quadriceps strength
Time Frame: 12 weeks
|
Measured knee extension strength with a handheld dynamometer, expressed as peak force (Newtons)
|
12 weeks
|
Isometric quadriceps strength
Time Frame: 9 months
|
Measured knee extension strength with a handheld dynamometer, expressed as peak force (Newtons)
|
9 months
|
Knee extension active range of motion
Time Frame: Baseline
|
Measured with a digital goniometer (smartphone app)
|
Baseline
|
Knee extension active range of motion
Time Frame: 4 weeks
|
Measured with a digital goniometer (smartphone app)
|
4 weeks
|
Knee extension active range of motion
Time Frame: 12 weeks
|
Measured with a digital goniometer (smartphone app)
|
12 weeks
|
Knee extension active range of motion
Time Frame: 9 months
|
Measured with a digital goniometer (smartphone app)
|
9 months
|
Time taken to return to sporting activity
Time Frame: 9 months
|
Taken retrospectively at 9 months, number of days from surgery to full return to sport
|
9 months
|
Kinesiophobia
Time Frame: Baseline
|
Fear of movement as measured with the Tampa scale of kinesiophobia
|
Baseline
|
Kinesiophobia
Time Frame: 4 weeks
|
Fear of movement as measured with the Tampa scale of kinesiophobia
|
4 weeks
|
Kinesiophobia
Time Frame: 12 weeks
|
Fear of movement as measured with the Tampa scale of kinesiophobia
|
12 weeks
|
Kinesiophobia
Time Frame: 9 months
|
Fear of movement as measured with the Tampa scale of kinesiophobia
|
9 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Maria V. Sanchez-Vives, Institut d'Investigacions Biomèdiques August Pi i Sunyer
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2021
Primary Completion (Actual)
November 15, 2023
Study Completion (Actual)
December 15, 2023
Study Registration Dates
First Submitted
September 20, 2021
First Submitted That Met QC Criteria
October 4, 2021
First Posted (Actual)
October 18, 2021
Study Record Updates
Last Update Posted (Actual)
April 18, 2024
Last Update Submitted That Met QC Criteria
April 16, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HCB-2019-0670
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Knee Injuries
-
Mayo ClinicCompletedArthroplasty, Replacement, Knee | Injuries, KneeUnited States
-
Wake Forest University Health SciencesTerminatedInjuries, KneeUnited States
-
Poitiers University HospitalWithdrawn
-
Universidad de ZaragozaUnknownAnterior Cruciate Ligament Injuries | Injuries, Knee | Prevention & ControlSpain
-
Tissue Regenix LtdNot yet recruitingMultiligament Knee Injuries
-
Istituto Ortopedico RizzoliNot yet recruitingStiffness of Knee, Not Elsewhere Classified | Knee FracturesItaly
-
Medipol UniversityRecruitingKnee Osteoarthritis | Knee Injuries | Knee Arthritis | Knee DiseaseTurkey
-
University of PittsburghMayo Clinic; University of Missouri-Columbia; Washington University School of... and other collaboratorsRecruitingKnee Dislocations | Multiple Ligament Knee InjuriesUnited States
-
Technical University of MunichCompleted
-
Universidad de GranadaCompletedKnee Injuries and DisordersSpain
Clinical Trials on Virtual reality
-
Institut National de la Santé Et de la Recherche...Not yet recruitingSchizophrenia | Bipolar Disorder
-
Eskisehir Osmangazi UniversityNot yet recruiting
-
The University of Hong KongRecruiting
-
Universidad Rey Juan CarlosCompleted
-
University of PennsylvaniaNot yet recruitingEnd Stage Kidney Disease
-
National University of MalaysiaRecruitingPleural EffusionMalaysia
-
Stanford UniversityTerminatedConversion Disorder | Non-epileptic Seizures | Functional Neurological Disorder | Functional Movement Disorder | Psychogenic Movement DisorderUnited States
-
University of WashingtonNational Institutes of Health (NIH); University of Texas; National Institute...Completed
-
Centre Hospitalier Universitaire de Saint EtienneInstitut de Cancérologie de la Loire; Gustave Roussy, Cancer Campus, Grand... and other collaboratorsTerminated
-
Hacettepe UniversityRecruitingGonarthrosis; PrimaryTurkey